Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)

Resistance to Targeted
Wo zu kaufen (2) Eigenschaften
Gesponsert
Resistance to Targeted Therapies in Breast Cancer (Resistance to Targeted Anti-Cancer Therapeutics)
Medimops DE
145.96 EUR
Preis aktualisiert am: 14-06-2026 18:21:12
Siehe Produktangebot
Gesponsert
Resistance to Targeted Therapies in Breast Cancer
SpringerLink DE
160.49 EUR
Preis aktualisiert am: 15-06-2026 01:06:24
Siehe Produktangebot

Allgemein

Marke
Springer

Eigenschaften

Ähnliche Produkte

TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)
TRAIL, Fas Ligand, TNF and TLR3 in Cancer (Resistance to Targeted Anti-Cancer Therapeutics, Band 12)
Produkt anzeigen
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics, Band 17)
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics, Band 17)
Produkt anzeigen
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Produkt anzeigen
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways (Resistance to Targeted Anti-Cancer Therapeutics, Band 15)
Produkt anzeigen
Resistance to Targeted Therapies in Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics (21), Band 21)
Resistance to Targeted Therapies in Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics (21), Band 21)
Produkt anzeigen
Resistance to Molecular Therapies for Hepatocellular Carcinoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 13)
Resistance to Molecular Therapies for Hepatocellular Carcinoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 13)
Produkt anzeigen
Menü